Live feed
Filing
SC 13D
SC 13D0001628280-22-030420·BELLICUM PHARMACEUTICALS, INC
Schedule 13D ownership disclosure
BELLICUM PHARMACEUTICALS, INC
Security class unavailable · CUSIP: 079481404
Event date: 2022-09-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001628280-22-030420
- Form type
- SC 13D
- Filer
- BELLICUM PHARMACEUTICALS, INC
- CIK
- CIK 1358403
- Filed
- Nov 18, 2022
- Reporting period
- Sep 30, 2022
- Description
- Schedule 13D beneficial ownership